TRANSENTERIX INC's ticker is TRXC and the CUSIP is 89366M201. A total of 156 filers reported holding TRANSENTERIX INC in Q3 2018. The put-call ratio across all filers is 1.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $320,000 | +185.7% | 516,881 | +528.3% | 0.00% | – |
Q2 2019 | $112,000 | +45.5% | 82,273 | +154.4% | 0.00% | – |
Q1 2019 | $77,000 | -97.4% | 32,344 | -95.2% | 0.00% | -100.0% |
Q2 2018 | $2,966,000 | -7.9% | 680,152 | -64.1% | 0.00% | 0.0% |
Q1 2018 | $3,222,000 | +682.0% | 1,895,115 | +787.5% | 0.00% | +300.0% |
Q4 2017 | $412,000 | -75.9% | 213,532 | -82.2% | 0.00% | -66.7% |
Q3 2017 | $1,713,000 | +155.3% | 1,197,754 | +26.8% | 0.00% | +200.0% |
Q2 2017 | $671,000 | +139.6% | 944,408 | +307.5% | 0.00% | 0.0% |
Q1 2017 | $280,000 | -54.1% | 231,784 | -50.6% | 0.00% | 0.0% |
Q4 2016 | $610,000 | +970.2% | 469,484 | +898.3% | 0.00% | – |
Q2 2016 | $57,000 | -75.3% | 47,029 | -13.5% | 0.00% | – |
Q1 2016 | $231,000 | -11.5% | 54,376 | -48.2% | 0.00% | -100.0% |
Q4 2015 | $261,000 | +54.4% | 105,047 | +40.7% | 0.00% | – |
Q3 2015 | $169,000 | -91.5% | 74,676 | -88.7% | 0.00% | -100.0% |
Q2 2015 | $1,983,000 | +531.5% | 660,978 | +516.2% | 0.00% | +300.0% |
Q1 2015 | $314,000 | +79.4% | 107,268 | +78.0% | 0.00% | – |
Q4 2014 | $175,000 | +21.5% | 60,260 | +111.6% | 0.00% | – |
Q2 2014 | $144,000 | – | 28,475 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SV Health Investors, LLC | 7,546,692 | $12,829,000 | 9.62% |
StepStone Group LP | 3,032,625 | $5,155,000 | 3.79% |
Aisling Capital LLC | 9,889,352 | $16,812,000 | 3.00% |
PACIFIC VIEW ASSET MANAGEMENT, LLC | 519,548 | $883,000 | 0.66% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 889,082 | $1,503,000 | 0.59% |
MASTERS CAPITAL MANAGEMENT LLC | 4,000,000 | $6,800,000 | 0.15% |
Tibra Equities Europe Ltd | 335,565 | $570,000 | 0.10% |
BRANDYWINE MANAGERS, LLC | 94,583 | $161,000 | 0.09% |
SABBY MANAGEMENT, LLC | 513,430 | $872,000 | 0.05% |
ACUTA CAPITAL PARTNERS, LLC | 180,000 | $307,000 | 0.05% |